Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors

December 16, 2010 6:31 am | by RealWire | News | Comments

PHILADELPHIA, PA, 16 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market...

TOPICS:

Nichrome Sealing Wire Teflon Coated To Prevent Sticking

December 16, 2010 6:18 am | Applied Plastics Co., Inc. | Product Releases | Comments

A new line of nichrome resistance wire that is coated with DuPont Teflon to create a non-stick surface for use at high temperatures is being introduced by Applied Plastics Co. Inc.

NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial

December 16, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Dec. 16, 2010 /- Novavax, Inc. (Nasdaq: NVAX ) announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no...

TOPICS:
Advertisement

FDA Safety Notification: Risk of Eye and Skin Injuries from High-powered, Hand-held Lasers Used for Pointing or Entertainment

December 16, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is alerting consumers about the risk of eye and skin injuries from exposure to high-powered laser pointers. FDA regulations limit the energy output of hand-held laser pointers to 5 milliwatts (mW).

TOPICS:

Judge invalidates state contract to Blue Cross

December 16, 2010 4:45 am | by The Associated Press | News | Comments

A judge Wednesday invalidated a contract the state awarded to Blue Cross and Blue Shield of Louisiana to administer the HMO plan for state workers, retirees and their dependents.State District Judge Mike Caldwell agreed with attorneys for Humana and UnitedHealthcare that the contract awarded...

Is OSRAM for sale?

December 16, 2010 4:34 am | by I-Micronews | News | Comments

Siemens AG, Europe’s largest engineering company, is exploring options for its Osram lighting business, including a possible initial public offering or sale, according to three people with knowledge of the discussions. Siemens, ...

First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary

December 16, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass., Dec. 16, 2010 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their seven-year anniversary of home hemodialysis treatment with the NxStage® System...

TOPICS:

New Topical Research Reports by iData Research Published by MarketPublishers.com

December 16, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 16, 2010 /- Market Publishers Ltd informs that new in-demand market research reports by iData Research have been added to its catalogue. Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 . In 2010, the Asia Pacific markets for...

TOPICS:
Advertisement

Guardian 24/7 Offers Remote High-Touch Health Care via Glowpoint Video Managed Services

December 16, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

HILLSIDE, N.J., Dec. 16, 2010 /- Glowpoint, Inc. (OTC Bulletin Board: GLOW ), a provider of cloud-based managed services for telepresence , video conferencing and collaboration , today announced that Guardian 24/7, a health care provider for high-profile executives, has selected...

TOPICS:

Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly

December 16, 2010 2:31 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the...

TOPICS:

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO and ILLKIRCH, France, Dec. 16, 2010 /- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a...

TOPICS:

Watson and Richter Announce Exclusive License Agreement for Esmyaâ„¢

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A.,...

TOPICS:

Okla. set to execute inmate with substitute drug

December 15, 2010 10:45 pm | by SEAN MURPHY - Associated Press - Associated Press | News | Comments

A man on Oklahoma's death row for the 2001 slaying of his cellmate is believed to be the first U.S. inmate set to be executed using a sedative commonly used to euthanize animals.John David Duty is set to die at 6 p.m. Thursday at the Oklahoma State Penitentiary in McAlester. A federal appeals...

Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology

December 15, 2010 8:32 pm | by EurekAlert | News | Comments

(Burness Communications) The Presidential Commission for the Study of Bioethical Issues today released its first report -- a wide-ranging review of the emerging field of synthetic biology -- issuing 18 recommendations including a call for coordinated federal oversight of scientists...

TOPICS:

Cell-Seeded Sutures to Repair the Heart

December 15, 2010 7:32 pm | by Massachusetts Institute of Technology | News | Comments

Polymer threads coated with stem cells might one day heal damaged cardiac muscle.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading